LIFETECH SCIENTIFIC CORPORATION LifeTech Scientific Corporation Stock
Equities
1302
KYG548721177
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.65 HKD | +0.61% |
|
+3.77% | -29.79% |
| Apr. 11 | Lifetech Scientific Buys Shares For Employee Incentive Scheme | MT |
| Apr. 04 | Lifetech Scientific Unit Invests 340 Million Yuan in Structured Deposits | MT |
| Sales 2024 * | 1.47B 203M 1.59B | Sales 2025 * | 1.77B 245M 1.92B | Capitalization | 7.03B 970M 7.59B |
|---|---|---|---|---|---|
| Net income 2024 * | 328M 45.27M 354M | Net income 2025 * | 399M 55.07M 431M | EV / Sales 2024 * | 4.77 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 3.96 x |
| P/E ratio 2024 * |
21.7
x | P/E ratio 2025 * |
16.9
x | Employees | 1,448 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.41% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.61% | ||
| 1 week | +3.77% | ||
| Current month | -6.25% | ||
| 1 month | -5.17% | ||
| 3 months | -12.70% | ||
| 6 months | -26.01% | ||
| Current year | -29.79% |
1 week
1.59
1.66
1 month
1.561.82
Current year
1.562.39
1 year
1.563.02
3 years
1.565.86
5 years
1.135.98
10 years
0.725.98
| Managers | Title | Age | Since |
|---|---|---|---|
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Xiong Liu
DFI | Director of Finance/CFO | 53 | 10-08-31 |
Feng Jiang
BRD | Director/Board Member | 61 | 14-03-31 |
Yue Hui Xie
CEO | Chief Executive Officer | 54 | 06-08-16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.16% | 2 M€ | -14.14% | ||
| 0.02% | 117 M€ | +0.16% | - | |
| 0.02% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 1.65 | +0.61% | 690 000 |
| 24-04-25 | 1.64 | 0.00% | 2,673,300 |
| 24-04-24 | 1.64 | +1.86% | 3,382,000 |
| 24-04-23 | 1.61 | +0.63% | 3,734,000 |
| 24-04-22 | 1.6 | +0.63% | 4,442,000 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 11:58 pm EDT
More quotes
LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.
Calendar
2024-05-26
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.518
CNY
Average target price
2.436
CNY
Spread / Average Target
+60.50%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.79% | 970M | |
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.57% | 62.51B | |
| +15.42% | 52.98B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B |
- Stock Market
- Equities
- 1302 Stock
